跳至主要内容
临床试验/RBR-8wnrg48
RBR-8wnrg48进行中(未招募)不适用

Impact of anti-androgen therapy on body composition, strength and quality of life in prostate cancer patients

Faculdade de Medicina de São José do Rio Preto - FAMERP0 个研究点开始时间: 2022年2月18日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65Y 至 0(—)
性别
Male

入选标准

  • Prostate cancer patients over 65 years old; Metastatic disease in sensitive castration scenario; Patients in biochemical recurrence (ASTRO definition); Intermittent hormonal blockade, with last dose of anti-androgen >6 months ago

排除标准

  • Radiotherapy or Chemotherapy in the last 30 days; Heart attack in the last 30 days; Neuromuscular disorders, hemiplegia or osteoarticular deformities of the upper/lower limbs

研究者

发起方
Faculdade de Medicina de São José do Rio Preto - FAMERP

相似试验

招募中
不适用
To determine whether androgen deprivation therapy or androgen blockage therapy upregulates receptor activity of Gallium68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans for men with castrate resistant prostate cancer.Metastatic Prostate Cancer
ACTRN12617001116314St Vincent's Hospital, Sydney20
进行中(未招募)
不适用
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate CancerCardiovascular InjuryProstate Carcinoma
NCT02722525Ohio State University Comprehensive Cancer Center23
进行中(未招募)
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancer
EUCTR2018-004853-26-FITurku University Hospital35
进行中(未招募)
1 期
The effect of androgen deprivation therapy on prostate specific membrane antigen (PSMA)Prostate cancer
EUCTR2017-002345-29-FITurku University Hospital5
已完成
4 期
Study to Monitor the Effects of Androgen Suppression Treatment on the HeartProstate Cancer
NCT01230905Ottawa Heart Institute Research Corporation181
Impact of hormone therapy on body, strength and... | 临床试验